BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
biote Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$1.08−0.00 (-0.46%)
Close on Oct 19, 2026
- Market cap
- $30.92M
- P/E (TTM)
- 10.8
- Dividend yield
- –
biote Corp. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Product Revenue | $186.92M | $192.24M | $182.57M | $163.13M | $137.60M | 97.2% | -2.8% |
| Pellet Procedures Product Revenue | $137.04M | $150.33M | $140.99M | $128.95M | $109.47M | 71.3% | -8.8% |
| Dietary Supplements | $42.88M | $36.02M | $38.09M | $32.41M | $27.24M | 22.3% | +19.1% |
| Service Revenue | $5.30M | $4.95M | $2.79M | $1.82M | $1.80M | 2.8% | +6.9% |
| Disposable Trocars Product Revenue | $4.85M | $4.35M | $3.32M | $1.70M | $860.00K | 2.5% | +11.7% |
| Other Service Revenue | $2.86M | $2.27M | $697.00K | – | – | 1.5% | +25.9% |
| Shipping Fees And Other Product Revenue | $2.15M | $1.55M | $172.00K | – | – | 1.1% | +38.9% |
| Contract-Term Services Revenue | $1.36M | $1.23M | $920.00K | $851.00K | $939.00K | 0.7% | +11.1% |
| Training Service Revenue | $1.08M | $1.46M | $1.17M | $973.00K | $859.00K | 0.6% | -26.1% |
| Shipping Fees Product Revenue | – | – | $172.00K | $71.00K | $32.00K | – | – |
By region
From the segment and revenue-disaggregation notes of biote's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.